
METTL16 is critical modulator of proteasome inhibitor resistance in multiple myeloma, acting through an m⁶A‑independent translational mechanism that enhances PERK–eIF2α dysregulation. Read more >>>>
nature.com/articles/s4138…
English
Oncogene Journal
1.1K posts

@oncogenejournal
Oncogene aims to make substantial advances in our knowledge of processes that contribute to cancer by publishing outstanding research.



















